Literature DB >> 16929142

Obesity and renal hemodynamics.

R J Bosma1, J A Krikken, J J Homan van der Heide, P E de Jong, G J Navis.   

Abstract

Obesity is a risk factor for renal damage in native kidney disease and in renal transplant recipients. Obesity is associated with several renal risk factors such as hypertension and diabetes that may convey renal risk, but obesity is also associated with an unfavorable renal hemodynamic profile independent of these factors, and that may exert effects on renal damage as well. In animal models of obesity-associated renal damage, micro-puncture studies showed glomerular hypertension and hyperfiltration. In humans an elevated glomerular filtration rate has been demonstrated in several studies, sometimes associated with hyperperfusion as well, independent of blood pressure or the presence of diabetes. An elevated filtration fraction was found in several studies, consistent with glomerular hypertension. This renal hemodynamic profile resembles the hyperfiltration pattern in diabetes and is therefore assumed to be a pathogenetic factor in renal damage. Of note, the association between body mass index and renal hemodynamics is not limited to overt obesity or overweight, but is also present across the normal range, without a particular threshold. Multiple factors are assumed to contribute to these renal hemodynamic alterations, such as insulin resistance, the renin-angiotensin system and the tubulo-glomerular responses to increased proximal sodium reabsorption, and possibly also inappropriate activity of the sympathetic nervous system and increased leptin levels. Obesity has a high world-wide prevalence. On a population-basis, therefore, its contribution to long-term renal risk may be considerable, especially as it is usually clustered with risk factors like hypertension and insulin resistance. In short-term studies the renal hemodynamic alterations in obesity and the associated proteinuria were reversible by weight loss, and renin-angiotensin system-blockade, respectively. These interventions are therefore likely to have the potential to limit the renal risks of obesity.

Entities:  

Mesh:

Year:  2006        PMID: 16929142     DOI: 10.1159/000095329

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  26 in total

1.  Progressive renal vascular proliferation and injury in obese Zucker rats.

Authors:  Radu Iliescu; Alejandro R Chade
Journal:  Microcirculation       Date:  2010-05       Impact factor: 2.628

2.  Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney.

Authors:  Allon N Friedman; Lorraine G Ogden; Gary D Foster; Samuel Klein; Richard Stein; Bernard Miller; James O Hill; Carrie Brill; Brooke Bailer; Diane R Rosenbaum; Holly R Wyatt
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-31       Impact factor: 8.237

3.  Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.

Authors:  Cyrus Ghobadi; Trevor N Johnson; Mohsen Aarabi; Lisa M Almond; Aurel Constant Allabi; Karen Rowland-Yeo; Masoud Jamei; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2011-12-01       Impact factor: 6.447

4.  Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study.

Authors:  Yvette Meuleman; Lucia Ten Brinke; Arjan J Kwakernaak; Liffert Vogt; Joris I Rotmans; Willem Jan W Bos; Paul J M van der Boog; Gerjan Navis; Gert A van Montfrans; Tiny Hoekstra; Friedo W Dekker; Sandra van Dijk
Journal:  Int J Behav Med       Date:  2015-08

5.  Blood pressure and diabetic nephropathy.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-03       Impact factor: 19.112

6.  Body weight control by a high-carbohydrate/low-fat diet slows the progression of diabetic kidney damage in an obese, hypertensive, type 2 diabetic rat model.

Authors:  Shuichi Ohtomo; Yuko Izuhara; Masaomi Nangaku; Takashi Dan; Sadayoshi Ito; Charles van Ypersele de Strihou; Toshio Miyata
Journal:  J Obes       Date:  2010-02-17

Review 7.  Appendicitis in obese children.

Authors:  Balazs Kutasy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-03-10       Impact factor: 1.827

8.  Obesity and impaired renal function: potential for lifestyle intervention?

Authors:  Eva Corpeleijn; Stephan J L Bakker; Ronald P Stolk
Journal:  Eur J Epidemiol       Date:  2009-05-07       Impact factor: 8.082

9.  Ischemia heart disease and greater waist circumference are risk factors of renal function deterioration in male gout patients.

Authors:  Ben Yu-Jih Su; Han-Ming Lai; Chung-Jen Chen; Ying-Chou Chen; Chun-Kai Chiu; Ko-Ming Lin; Shan-Fu Yu; Tien-Tsai Cheng
Journal:  Clin Rheumatol       Date:  2007-11-20       Impact factor: 2.980

Review 10.  Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension.

Authors:  Edward D Frohlich; Dinko Susic
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.